{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1362544420026024576.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1074/jbc.m009483200"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0021925819346721?httpAccept=text/xml"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0021925819346721?httpAccept=text/plain"}},{"identifier":{"@type":"URI","@value":"https://syndication.highwire.org/content/doi/10.1074/jbc.M009483200"}},{"identifier":{"@type":"NAID","@value":"80012179126"}}],"dc:title":[{"@value":"High Resolution Mapping of the Binding Site on Human IgG1 for FcγRI, FcγRII, FcγRIII, and FcRn and Design of IgG1 Variants with Improved Binding to the FcγR"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1382544420026024578","@type":"Researcher","foaf:name":[{"@value":"Robert L. Shields"}]},{"@id":"https://cir.nii.ac.jp/crid/1382544420026024705","@type":"Researcher","foaf:name":[{"@value":"Angela K. Namenuk"}]},{"@id":"https://cir.nii.ac.jp/crid/1382544420026024707","@type":"Researcher","foaf:name":[{"@value":"Kyu Hong"}]},{"@id":"https://cir.nii.ac.jp/crid/1382544420026024576","@type":"Researcher","foaf:name":[{"@value":"Y. Gloria Meng"}]},{"@id":"https://cir.nii.ac.jp/crid/1382544420026024577","@type":"Researcher","foaf:name":[{"@value":"Julie Rae"}]},{"@id":"https://cir.nii.ac.jp/crid/1382544420026024579","@type":"Researcher","foaf:name":[{"@value":"John Briggs"}]},{"@id":"https://cir.nii.ac.jp/crid/1382544420026024710","@type":"Researcher","foaf:name":[{"@value":"Dong Xie"}]},{"@id":"https://cir.nii.ac.jp/crid/1382544420026024704","@type":"Researcher","foaf:name":[{"@value":"Jadine Lai"}]},{"@id":"https://cir.nii.ac.jp/crid/1382544420026024708","@type":"Researcher","foaf:name":[{"@value":"Andrew Stadlen"}]},{"@id":"https://cir.nii.ac.jp/crid/1382544420026024711","@type":"Researcher","foaf:name":[{"@value":"Betty Li"}]},{"@id":"https://cir.nii.ac.jp/crid/1382544420026024706","@type":"Researcher","foaf:name":[{"@value":"Judith A. Fox"}]},{"@id":"https://cir.nii.ac.jp/crid/1382544420026024709","@type":"Researcher","foaf:name":[{"@value":"Leonard G. Presta"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"00219258"}],"prism:publicationName":[{"@value":"Journal of Biological Chemistry"}],"dc:publisher":[{"@value":"Elsevier BV"}],"prism:publicationDate":"2001-03","prism:volume":"276","prism:number":"9","prism:startingPage":"6591","prism:endingPage":"6604"},"reviewed":"false","dc:rights":["https://www.elsevier.com/tdm/userlicense/1.0/","http://creativecommons.org/licenses/by/4.0/"],"url":[{"@id":"https://api.elsevier.com/content/article/PII:S0021925819346721?httpAccept=text/xml"},{"@id":"https://api.elsevier.com/content/article/PII:S0021925819346721?httpAccept=text/plain"},{"@id":"https://syndication.highwire.org/content/doi/10.1074/jbc.M009483200"}],"createdAt":"2002-07-26","modifiedAt":"2024-01-04","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1050306506453924608","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Anti-Bovine Programmed Death-1 Rat-Bovine Chimeric Antibody for Immunotherapy of Bovine Leukemia Virus Infection in Cattle"}]},{"@id":"https://cir.nii.ac.jp/crid/1050564285808127360","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Glycosylation engineering of therapeutic IgG antibodies: challenges for the safety, functionality and efficacy"}]},{"@id":"https://cir.nii.ac.jp/crid/1050587981430440960","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"In vitro and in vivo antivirus activity of an anti-programmed death-ligand 1 (PD-L1) rat-bovine chimeric antibody against bovine leukemia virus infection"}]},{"@id":"https://cir.nii.ac.jp/crid/1050856995321770880","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"An affinity-matured human monoclonal antibody targeting fusion loop epitope of dengue virus with in vivo therapeutic potency"},{"@value":"An affinity-matured human monoclonal antibody targeting fusion loop epitope of dengue virus with\n                  <i>in vivo</i>\n                  therapeutic potency"}]},{"@id":"https://cir.nii.ac.jp/crid/1360002220793703424","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Augmentation of antibody-dependent cellular cytotoxicity with defucosylated monoclonal antibodies in patients with GI-tract cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004232093052928","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Avian IgY is selectively incorporated into the egg yolks of oocytes by discriminating Fc amino acid residues located on the Cυ3/Cυ4 interface"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004232513606272","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"TIM-3 Is a Promising Target to Selectively Kill Acute Myeloid Leukemia Stem Cells"}]},{"@id":"https://cir.nii.ac.jp/crid/1360021389807152384","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"FcRY is a key molecule controlling maternal blood IgY transfer to yolks during egg development in avian species"}]},{"@id":"https://cir.nii.ac.jp/crid/1360283690776070784","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Antibody with an engineered Fc region as a therapeutic agent against dengue virus infection"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285706395680512","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Comprehensive Characterization of Relationship Between Higher-Order Structure and FcRn Binding Affinity of Stress-Exposed Monoclonal Antibodies"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285709589276544","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Glycosylation of IgG-Fc: a molecular perspective"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285710510437120","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Influence of <scp>PD</scp>‐<scp>L</scp>1 cross‐linking on cell death in <scp>PD</scp>‐<scp>L</scp>1‐expressing cell lines and bovine lymphocytes"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285712577275520","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"B Cell-Based Seamless Engineering of Antibody Fc Domains"}]},{"@id":"https://cir.nii.ac.jp/crid/1360290617516672768","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Anti-Metastatic Activity of an Anti-EGFR Monoclonal Antibody against Metastatic Colorectal Cancer with KRAS p.G13D Mutation"}]},{"@id":"https://cir.nii.ac.jp/crid/1360298755604981760","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Biophysical Characterization of the Contribution of the Fab Region to the IgG-FcγRIIIa Interaction"}]},{"@id":"https://cir.nii.ac.jp/crid/1360565167734749184","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Cross-protective potential of anti-nucleoprotein human monoclonal antibodies against lethal influenza A virus infection"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567183438333696","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Assessing the Heterogeneity of the Fc-Glycan of a Therapeutic Antibody Using an engineered FcγReceptor IIIa-Immobilized Column"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567183466367872","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Human IgG1 antibodies suppress angiogenesis in a target-independent manner"}]},{"@id":"https://cir.nii.ac.jp/crid/1360579813399415808","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"The Fab portion of immunoglobulin G has sites in the CL domain that interact with Fc gamma receptor IIIa"}]},{"@id":"https://cir.nii.ac.jp/crid/1360584341827385344","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Reinforced antimyeloma therapy via dual-lymphoid activation mediated by a panel of antibodies armed with bridging-BiTE"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848656931922944","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Development of cell-based assay for predictively evaluating the FcγR-mediated human immune cell activation by therapeutic monoclonal antibodies"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848660464267008","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Structural analysis of Fc/FcγR complexes: a blueprint for antibody design"}]},{"@id":"https://cir.nii.ac.jp/crid/1361694368239665792","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Effect of UVC Irradiation on the Oxidation of Histidine in Monoclonal Antibodies"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204200322944","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@value":"抗体医薬の現状と抗体工学の展望"},{"@language":"en","@value":"Antibody Medicine and the Prospect of Antibody Engineering"},{"@language":"ja-Kana","@value":"コウタイ イヤク ノ ゲンジョウ ト コウタイ コウガク ノ テンボウ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204275281536","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Pharmacological and clinical profile of golimumab （Simponi<sup>®</sup>）"},{"@language":"ja","@value":"ゴリムマブ（シンポニー<sup>®</sup>）の薬理学的特徴および臨床試験成積"},{"@value":"新薬紹介総説 ゴリムマブ(シンポニー)の薬理学的特徴および臨床試験成績"},{"@language":"ja-Kana","@value":"シンヤク ショウカイ ソウセツ ゴリムマブ(シンポニー)ノ ヤクリガクテキ トクチョウ オヨビ リンショウ シケン セイセキ"},{"@value":"Pharmacological and clinical profile of golimumab （Simponi^|^reg;）"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204369500416","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"The Current Stream and Prospect of Glycoscience Application-Therapeutic Antibodies-"},{"@value":"糖鎖に関わる応用研究の潮流と展開―抗体医薬―"},{"@language":"ja-Kana","@value":"トウサ ニ カカワル オウヨウ ケンキュウ ノ チョウリュウ ト テンカイ コウタイ イヤク"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204640988800","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Antibody-based cancer therapy"},{"@value":"抗がん剤のｍｏｌｅｃｕｌａｒ　ｔａｒｇｅｔｉｎｇ　　癌の抗体療法"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205207365376","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Maternal Transfer of Immunoglobulins into Egg Yolks of Birds"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001206127464576","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"タンデムFc化による抗体依存性細胞傷害活性の増強"},{"@language":"en","@value":"Enhancement of Antibody-dependent Cellular Cytotoxicity by Tandem Fc Multimerization"},{"@language":"ja-Kana","@value":"タンデム Fcカ ニ ヨル コウタイ イゾンセイ サイボウ ショウガイ カッセイ ノ ゾウキョウ"},{"@value":"ChemInform Abstract: Enhancement of Antibody‐Dependent Cellular Cytotoxicity by Tandem Fc Multimerization"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001206127801472","@type":"Article","relationType":["isReferencedBy","isCitedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"次世代抗体医薬としてのポテリジェント抗体"},{"@language":"en","@value":"Potelligent Antibodies as Next Generation Therapeutic Antibodies"},{"@language":"ja-Kana","@value":"ジセダイ コウタイ イヤク ト シテノ ポテリジェント コウタイ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679122216320","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Functional glycomics and evidence for gain- and loss-of-functions of target proteins for glycosyltransferases involved in <i>N</i>-glycan biosynthesis: their pivotal roles in growth and development, cancer metastasis and antibody therapy against cancer"},{"@value":"Functional glycomics and evidence for gain- and loss-of-functions of target proteins for glycosyltransferases involved in N-glycan biosynthesis: their pivotal roles in growth and development, cancer metastasis and antibody therapy against cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679617536256","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Development of next-generation antibody therapeutics by improving effector functions"},{"@language":"ja","@value":"プロテインエンジニアリングを利用した次世代バイオ創薬　　エフェクター機能の増強による次世代抗体医薬の開発"},{"@value":"エフェクター機能の増強による次世代抗体医薬の開発"},{"@language":"ja-Kana","@value":"エフェクター キノウ ノ ゾウキョウ ニ ヨル ジセダイ コウタイ イヤク ノ カイハツ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390564238018673024","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"抗体医薬の現状と展望(セミナー)"}]},{"@id":"https://cir.nii.ac.jp/crid/1520290883235495040","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@value":"フコース欠失による抗体エフェクター活性の向上"},{"@language":"ja-Kana","@value":"フコース ケッシツ ニ ヨル コウタイ エフェクター カッセイ ノ コウジョウ"}]},{"@id":"https://cir.nii.ac.jp/crid/1520291855743746560","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@value":"TNF receptor 2 fusion protein with tandemly repeated Fc domains"},{"@language":"ja-Kana","@value":"TNF receptor 2 fusion protein with tandemly repeated Fc domains"}]},{"@id":"https://cir.nii.ac.jp/crid/1521136280057845632","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@value":"有馬啓記念バイオインダストリー協会賞受賞論文 糖鎖改変による抗体機能の向上に関する研究"},{"@language":"ja-Kana","@value":"アリマケイキネン バイオインダストリー キョウカイショウ ジュショウ ロンブン トウサ カイヘン ニ ヨル コウタイ キノウ ノ コウジョウ ニ カンスル ケンキュウ"}]},{"@id":"https://cir.nii.ac.jp/crid/1521980705269114496","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@value":"Fucose Removal from Complex-Type Oligosaccharide Enhances the Antibody-Dependent Cellular Cytotoxicity of Single-Gene-Encoded Bispecific Antibody Comprising of Two Single-Chain Antibodies Linked to the Antibody Constant Region"},{"@language":"ja-Kana","@value":"Fucose Removal from Complex Type Oligosaccharide Enhances the Antibody Dependent Cellular Cytotoxicity of Single Gene Encoded Bispecific Antibody Comprising of Two Single Chain Antibodies Linked to the Antibody Constant Region"}]},{"@id":"https://cir.nii.ac.jp/crid/1571135649833961984","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Differences in promiscuity for antibody-FcRn interactions across species : implications for therapeutic antibodies"}]},{"@id":"https://cir.nii.ac.jp/crid/1571980075270420608","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Enhanced half-life of genetically engineered human IgG1 antibodies in a humanized FcRn mouse model : potential application in humorally mediated autoimmune disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1572543024818639488","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Evidence to support the cellular mechanism involved in serum IgG homeostasis in humans"}]},{"@id":"https://cir.nii.ac.jp/crid/1573105976023837696","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Engineered therapeutic antibodies with improved effector functions"}]},{"@id":"https://cir.nii.ac.jp/crid/1574231875930457344","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Engineered anti-CD20 antibodies with enhanced complement-activating capacity mediate potent anti-lymphoma activity"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1074/jbc.m009483200"},{"@type":"CIA","@value":"80012179126"},{"@type":"CROSSREF","@value":"10.1007/s13238-017-0433-3_references_DOI_36tu9RihyBrIEGS6ivyLsQF8BpL"},{"@type":"CROSSREF","@value":"10.1371/journal.pone.0174916_references_DOI_36tu9RihyBrIEGS6ivyLsQF8BpL"},{"@type":"CROSSREF","@value":"10.1016/j.bbrc.2017.02.050_references_DOI_36tu9RihyBrIEGS6ivyLsQF8BpL"},{"@type":"CROSSREF","@value":"10.3389/fimmu.2024.1305587_references_DOI_36tu9RihyBrIEGS6ivyLsQF8BpL"},{"@type":"CROSSREF","@value":"10.1101/2020.10.03.324731_references_DOI_36tu9RihyBrIEGS6ivyLsQF8BpL"},{"@type":"CROSSREF","@value":"10.1007/s11095-015-1845-5_references_DOI_36tu9RihyBrIEGS6ivyLsQF8BpL"},{"@type":"CROSSREF","@value":"10.1093/intimm/dxx038_references_DOI_36tu9RihyBrIEGS6ivyLsQF8BpL"},{"@type":"CROSSREF","@value":"10.1111/imm.12243_references_DOI_36tu9RihyBrIEGS6ivyLsQF8BpL"},{"@type":"CROSSREF","@value":"10.1371/journal.pone.0167232_references_DOI_36tu9RihyBrIEGS6ivyLsQF8BpL"},{"@type":"CROSSREF","@value":"10.3389/fimmu.2017.00650_references_DOI_36tu9RihyBrIEGS6ivyLsQF8BpL"},{"@type":"CROSSREF","@value":"10.2141/jpsa.0120194_references_DOI_36tu9RihyBrIEGS6ivyLsQF8BpL"},{"@type":"CROSSREF","@value":"10.1254/fpj.141.275_references_DOI_36tu9RihyBrIEGS6ivyLsQF8BpL"},{"@type":"CROSSREF","@value":"10.2745/dds.26.611_references_DOI_36tu9RihyBrIEGS6ivyLsQF8BpL"},{"@type":"CROSSREF","@value":"10.3390/ijms21176037_references_DOI_36tu9RihyBrIEGS6ivyLsQF8BpL"},{"@type":"CROSSREF","@value":"10.1038/s41598-021-92403-9_references_DOI_36tu9RihyBrIEGS6ivyLsQF8BpL"},{"@type":"CROSSREF","@value":"10.1021/acs.biochem.1c00832_references_DOI_36tu9RihyBrIEGS6ivyLsQF8BpL"},{"@type":"CROSSREF","@value":"10.1099/jgv.0.000518_references_DOI_36tu9RihyBrIEGS6ivyLsQF8BpL"},{"@type":"CROSSREF","@value":"10.1038/s41598-018-22199-8_references_DOI_36tu9RihyBrIEGS6ivyLsQF8BpL"},{"@type":"CROSSREF","@value":"10.1038/sigtrans.2015.1_references_DOI_36tu9RihyBrIEGS6ivyLsQF8BpL"},{"@type":"CROSSREF","@value":"10.1248/yakushi.129.3_references_DOI_36tu9RihyBrIEGS6ivyLsQF8BpL"},{"@type":"CROSSREF","@value":"10.2183/pjab.80.82_references_DOI_36tu9RihyBrIEGS6ivyLsQF8BpL"},{"@type":"CROSSREF","@value":"10.1016/j.dci.2012.12.003_references_DOI_36tu9RihyBrIEGS6ivyLsQF8BpL"},{"@type":"CROSSREF","@value":"10.1080/19420862.2022.2038531_references_DOI_36tu9RihyBrIEGS6ivyLsQF8BpL"},{"@type":"CROSSREF","@value":"10.1182/blood.2022019082_references_DOI_36tu9RihyBrIEGS6ivyLsQF8BpL"},{"@type":"CROSSREF","@value":"10.1111/imr.12365_references_DOI_36tu9RihyBrIEGS6ivyLsQF8BpL"},{"@type":"CROSSREF","@value":"10.3892/ol.2017.7556_references_DOI_36tu9RihyBrIEGS6ivyLsQF8BpL"},{"@type":"CROSSREF","@value":"10.1016/j.stem.2010.11.014_references_DOI_36tu9RihyBrIEGS6ivyLsQF8BpL"},{"@type":"CROSSREF","@value":"10.1038/s41598-020-63078-5_references_DOI_36tu9RihyBrIEGS6ivyLsQF8BpL"},{"@type":"CROSSREF","@value":"10.1016/j.antiviral.2015.10.012_references_DOI_36tu9RihyBrIEGS6ivyLsQF8BpL"},{"@type":"CROSSREF","@value":"10.1248/yakushi.130.49_references_DOI_36tu9RihyBrIEGS6ivyLsQF8BpL"}]}